Abstract:BACKGROUND:Neoadjuvant chemotherapy (NAC) is an effective therapeutic regimen for patients with breast cancer. However, some individuals cannot benefit from NAC because of drug resistance. To date, valid strategies about enhancing sensitivity of breast cancer to NAC are still scarce. miRNAs have been reported to proverbially be involved in the onset and development of malignancies including drug resistance.METHODS:GSE73736 was downloaded from the GEO database. Student's t-test was conducted to acquire differentially expressed-miRNAs (DE-miRNAs). Potential target genes of DE-miRNAs were predicted by miRTarBase. Gene Ontology annotation and Kyoto Encyclopedia of Genes and Genomes pathway enrichment analyses for these target genes were performed by database for annotation, visualization, and integrated discovery. Protein-protein interaction network was constructed by STRING database and visualized through Cytoscape software. The hub target gene-miRNA network was also established by Cytoscape software. Next, the expression of potential functional miRNAs in breast cancer cell lines and tissues was determined. Finally, the roles of miR-3617-3p, miR-3136-3p, and miR-520b in modulating breast cancer chemoresistance were further examined.RESULTS:A total of 123 DE-miRNAs were identified, including 60 upregulated miRNAs and 63 downregulated miRNAs in the chemoresistant breast cancer group when compared with the chemosensitive group. Six hundred and seventeen and 1,146 potential target genes for the top 10 most upregulated and downregulated miRNAs were predicted, respectively. Enrichment analyses revealed that these target genes were enriched in some cancer-associated or chemo-resistance-associated pathways, such as MAPK signaling pathway, wnt signaling pathway, and p53 signaling pathway. MAPK1 and PRDM10 were identified as hub genes in the protein-protein interaction network. The top 25 hub genes were potentially regulated by 16 DE-miRNAs, among which miR-3617-3p and miR-3136-3p were commonly upregulated, whereas miR-520b was downregulated in two chemoresistant breast cancer cells compared with chemosensitive cell. By analyzing TCGA data, we found that expression of miR-3136-3p and miR-520b was increased and decreased in breast cancer tissues, respectively. Moreover, functional experiments demonstrated that miR-3136-3p and miR-3617-3p could reduce chemosensitivity of breast cancer, whereas miR-520b could reverse chemoresistance.CONCLUSION:The present study, based on bioinformatics analysis and experimental validation, brings to light novel mechanisms of breast cancer NAC resistance.

An Integrated Bioinformatics Analysis to Investigate the Targets of Mir-133A-1 in Breast Cancer

Mir-433 Inhibits Breast Cancer Cell Growth Via the MAPK Signaling Pathway by Targeting Rap1a

Tumor-promoting Properties of Mir-8084 in Breast Cancer Through Enhancing Proliferation, Suppressing Apoptosis and Inducing Epithelial–mesenchymal Transition

An Integrative Bioinformatics Analysis Identified Mir-375 As a Candidate Key Regulator of Malignant Breast Cancer

Mir-143-3p Targeting LIM Domain Kinase 1 Suppresses the Progression of Triple-Negative Breast Cancer Cells.

Integrated Study of Mir-215 Promoting Breast Cancer Cell Apoptosis by Targeting RAD54B

Identification of Chemoresistance-Associated Mirnas in Breast Cancer

Identification Of The Potential Targets Of Mir-143-3p In Colorectal Cancer Through Bioinformatics Analysis

Expression And Potential Molecular Mechanisms Of Mir-204-5p In Breast Cancer, Based On Bioinformatics And A Meta-Analysis Of 2,306 Cases

MiR-133b targets Sox9 to control pathogenesis and metastasis of breast cancer

Role of Downregulated Mir-133A-3p Expression in Bladder Cancer: a Bioinformatics Study

Methylation-mediated Silencing of Mir-133A-3p Promotes Breast Cancer Cell Migration and Stemness Via Mir-133A-3p/maml1/dnmt3a Positive Feedback Loop

The Identification of Novel Targets of Mir-16 and Characterization of Their Biological Functions in Cancer Cells

The Comprehensive Landscape of Mir-34A in Cancer Research

Mir-143-5p Suppresses Breast Cancer Progression by Targeting the HIF-1-related GLUT1 Pathway

Mir-195/Mir-497 Regulate CD274 Expression of Immune Regulatory Ligands in Triple-Negative Breast Cancer

Identification of Key Micrornas Involved in Tumorigenesis and Prognostic Micrornas in Breast Cancer

Utility of Mir‑133a‑3p As a Diagnostic Indicator for Hepatocellular Carcinoma: an Investigation Combined with GEO, TCGA, Meta‑analysis and Bioinformatics.

MicroRNA-3613-3p Functions As a Tumor Suppressor and Represents a Novel Therapeutic Target in Breast Cancer.

Identification Of Mir-133a-3p-Expression Signature And Probable Mechanism In Lung Squamous Cell Carcinoma: Insights From Integrated Analysis

Data from Identification of Mir-133B and RB1CC1 As Independent Predictors for Biochemical Recurrence and Potential Therapeutic Targets for Prostate Cancer